Christophe GUIGNABERT

Director of Research (DR1) - Full Professor of Molecular Biology & Physiology

INSERM

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Christophe Guignabert is a Director of Research (DR1) and Full Professor of Molecular Biology & Physiology at Inserm, France. His research primarily focuses on pulmonary arterial hypertension, with recent articles exploring novel drug pathways, the role of bone morphogenetic protein-9 in vascular growth, and the impact of medication adherence in affected patients. Guignabert's work bridges basic scientific research and the development of new therapeutic strategies for pulmonary hypertension.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (7)

Delphine Gras

Inserm u1183

FRANCE

View details

Andrea Olschewski

AUSTRIA

View details

FREDERIC FIORE

Head of Genetic Engineering Department, PhD

INSERM Délégation régionale Provence Alpes Cote d'Azur et Corse

FRANCE

View details

Olivier SITBON

FRANCE

View details

celine verstuyft

Full Professor of Pharmacology

FRANCE

View details

Ralph Schermuly

Professor

GERMANY

View details

Stephan Matecki

University of Montpellier

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christophe GUIGNABERT

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

[On your marks, get set, go for the 20th edition of J2R 2024 in Paris!]

Placental growth factor modulates endothelial NO production and exacerbates experimental hepatopulmonary syndrome

Drugs targeting novel pathways in pulmonary arterial hypertension

Bone morphogenetic protein-9 controls pulmonary vascular growth and remodeling.

Diuretic adherence in patients with precapillary pulmonary hypertension: insights from the PHARE study

From basic scientific research to the development of new drugs for pulmonary arterial hypertension: insights from activin-targeting agents

Pathology and pathobiology of pulmonary hypertension: current insights and future directions

Exploring the Endothelin-1 pathway in chronic thromboembolic pulmonary hypertension microvasculopathy.

Effect of Sotatercept on Circulating Proteomics in Pulmonary Arterial Hypertension.

Medication adherence, related factors and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: a systematic review

Collaborators (7)

Delphine Gras

Andrea Olschewski

FREDERIC FIORE

Olivier SITBON

celine verstuyft

Ralph Schermuly

Stephan Matecki

Make your next move.